Guidance and algorithm for follow-up of children after starting or transitioning to paediatric DTG 10 mg-based ART, dispensed in 90-tablet bottles

Overview

Purpose: Our purpose here is to aid health care workers and support caregivers and children initiated on, or switched to, pDTG-based ART to ensure that (1) the pDTG is being administered in the correct dosage and frequency; (2) health care workers and caregivers check for adverse drug reactions and signs of intolerance; and (3) follow-up is performed for scheduled clinical and ART pickup visits.

Note: The algorithm should be adapted to the country-specific context, policies, and guidelines, specifically to align with a country’s multimonth dispensing (MMD) and viral load testing schedules. Most countries currently allow MMD, mostly for children greater than 2 years old. To promote adaption, we are providing a soft document for easy editing.

Download the editable document (.docx).